Rubella vaccine, live-attenuated (Shanghai Institute of Biological Products)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRubella vaccine, live-attenuated (Shanghai Institute of Biological Products)
Drug Alias Namerubella vaccine (subcutaneous, live-attenuated), Shanghai Institute of Biological Products
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Vaccine type > Univalent vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRubella
Global Approved IndicationsRubella
Approved Indications in ChinaRubella
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Institute of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsRubella
Inactive IndicationsN/A

Other Information

ATC CodeJ07BJ01
Related LinksN/A